[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352566-105":59,"doc-detail-352566-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","effect-of-anticancer-activity-of-aripiprazole-main-metabolite-opc-14857-on-malignant-glioblastoma","Effect of anticancer activity of aripiprazole main metabolite OPC-14857 on malignant glioblastoma","","Glioblastoma is an incurable, highly malignant brain tumor with major challenges in surgery and chemotherapy. The antipsychotic drug aripiprazole (ARP) shows cytotoxic effects across cancers. This study compares ARP and its main metabolite OPC-14857 (OPC) using glioblastoma cell lines (U251, T98G, U87) to evaluate repurposing potential. Both OPC and ARP outperform temozolomide in inhibiting proliferation and migration, while OPC likely triggers G2/M arrest via actin-dependent changes, and both enhance doxorubicin efficacy and reduce survivin expression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/effect-of-anticancer-activity-of-aripiprazole-main-metabolite-opc-14857-on-malignant-glioblastoma/352566/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/effect-of-anticancer-activity-of-aripiprazole-main-metabolite-opc-14857-on-malignant-glioblastoma/352566.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study on OPC-14857?","Question",{"text":112,"@type":113},"To determine whether OPC-14857, the main metabolite of aripiprazole, has anticancer activity against malignant glioblastoma and can support drug repurposing for brain tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do ARP and OPC compare with temozolomide?",{"text":117,"@type":113},"Both ARP and OPC show more potent anti-cancer effects than temozolomide, including stronger inhibition of cell proliferation and cell migration.",{"name":119,"@type":110,"acceptedAnswer":120},"What cellular effects are proposed for OPC exposure?",{"text":121,"@type":113},"OPC exposure is suggested to induce G2/M phase cell cycle arrest and suppress proliferation and migration, potentially by affecting actin and altering its subcellular localization.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352566,1790400643,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","OPEN ACCESS  \nCitation: Nakao S, Uemichi Y, Nagano S, Mabuchi M, Ohmori S, Enomoto D, et al. (2026) Effect of anticancer activity of aripiprazole main metabolite OPC-14857 on malignant glioblastoma. PLoS One 21(3): e0338895 .  \n[https://doi.org/10.1371/journal.pone.0338895](https://doi.org/10.1371/journal.pone.0338895)  \nEditor: Mária A. Deli, Eötvös Loránd Research Network Biological Research Centre, HUNGARY Received: October 12, 2024  \nAccepted: November 28, 2025  \nPublished: March 13, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0338895  \nCopyright: © 2026 Nakao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  \nRESEARCH ARTICLE  \nEffect of anticancer activity of aripiprazole main metabolite OPC-14857 on malignant glioblastoma  \nShuhei Nakao1, Yuki Uemichi1, Shuji Nagano1, Miyuki Mabuchi1, Shiho Ohmori1, Daichi Enomoto1, Takehiko Ueyama2, Tadashi Shimizu1*  \n1 School of Pharmacy, Hyogo Medical University, Kobe, Hyogo, Japan, 2 Laboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe, Hyogo, Japan  \n* [shimizu-t@hyo-med.ac.jp](shimizu-t@hyo-med.ac.jp)  \nAbstract  \nGlioblastoma is an incurable and highly malignant brain tumor that poses challenges in surgical and chemotherapeutic treatments. Aripiprazole (ARP), an antipsychotic drug, exerts cytotoxic effects against various cancers. In the present study, we compared the inhibitory effect ofARP on cell proliferation with that of its main metabolite, OPC-14857 (OPC), using glioblastoma cell lines (U251, T98G, and U87 cells) to explore their potential for repurposing against brain tumors. Both demonstrated more potent anticancer activity than temozolomide, the current standard clinical therapy for malignant glioblastoma. Additionally, we assessed their effects on the cell cycle, cytoskeleton, cell migration, and protein expression. The anti-proliferative and anti-migratory activities of OPC were similar to those of ARP. Moreover, there were no differences in the effects of cell death inhibitors on the anticancer activities of ARP and OPC. However, the two compounds exhibited distinct activity profiles. Exposure to OPC was suggested to induce G2/M phase cell cycle arrest and to suppress cell proliferation and migration, potentially by affecting actin and altering its subcellular localization. ARP and OPC enhanced doxorubicin (DOX) efficacy, likely via P-glycoprotein inhibition; known for ARP, suggested for structurally similar OPC. Treatment with ARP or OPC reduced the expression of survivin, an anti-apoptotic protein, suggesting an increase in apoptotic susceptibility. Although our observations were limited to in vitro studies, our findings suggest that OPC may have sustained anticancer effects even when ARP is metabolized in humans. Therefore, if ARP can be used for drug repurposing in glioblastoma, the long-term effects of OPC could be anticipated.  \n1. Introduction  \nGlioblastoma is a highly malignant brain tumor and one of the deadliest of all carcinomas. The 5-year survival rate for affected patients is 6 .9%, and even in the group with the highest survival rate (15–39 years old), the survival rate is only 26 .6%[ 1] . At the time of diagnosis, it has typically diffusely infiltrated the brain, rendering complete surgical resection rarely  \nPLOS One | [https://doi.org/10.1371/journal.pone.0338895](https://doi.org/10.1371/journal.pone.0338895) March 13, 2026 1 / 16  \nand reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the manuscript and","cbCaihyriJuLPi6P","https://ap.wps.com/l/cbCaihyriJuLPi6P","pdf",2164022,16,"English","# Abstract\n## Introduction","[{\"question\":\"What is the main goal of this study on OPC-14857?\",\"answer\":\"To determine whether OPC-14857, the main metabolite of aripiprazole, has anticancer activity against malignant glioblastoma and can support drug repurposing for brain tumors.\"},{\"question\":\"How do ARP and OPC compare with temozolomide?\",\"answer\":\"Both ARP and OPC show more potent anti-cancer effects than temozolomide, including stronger inhibition of cell proliferation and cell migration.\"},{\"question\":\"What cellular effects are proposed for OPC exposure?\",\"answer\":\"OPC exposure is suggested to induce G2/M phase cell cycle arrest and suppress proliferation and migration, potentially by affecting actin and altering its subcellular localization.\"}]","Effect of anticancer activity of aripiprazole main metabolite OPC-14857 on malignant glioblastoma | PDF",1790100269,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61cd5dd66b8fc0707dca7906f0d679e5.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a872b2f340aca0af05c21a4d0dac34e9.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de6299f31b070d458afd5bf34b57fcf7.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/228b66ac6c8e8a51d05becf07e7af374.webp",980,1268]